KEYTRUDA
-
Merck Doubles Down on Domestic Manufacturing with $70 Billion Investment
Pharmaceutical giant Merck is boosting its U.S. investments to more than $70 billion, according to Reuters. The move underscores its commitment to strengthening domestic manufacturing…
-
Merck’s Oral Cholesterol Therapy Offers Easier Alternative to Injections
Merck, the pharmaceutical giant with multiple locations across Montco, is reporting success with a new oral cholesterol drug, according to Reuters. The drug, enlicitide decanoate,…
-
WSJ: Merck Makes $10 Billion Move as Keytruda Patent Expiration Nears
Merck is making big pharma waves again with a $10 billion deal to acquire Verona Pharma, reports Colin Kellaher for the Wall Street Journal. The…
-
Merck Expands Biomanufacturing with Staggering Investment in Wilmington
Merck, the Pharma giant with operations in Lansdale, announced on Tuesday that it will build a $1 billion “biologics center of excellence” in Wilmington, writes…
Founding Partners
Advertisement
Affiliate Partners
